Autism spectrum disorder is a neurological condition that can vary greatly in severity, from mild cases to more profound forms that require lifelong supportive care. The differences in the symptoms and challenges faced by individuals with autism have puzzled researchers for years. A recent study on mini-brains developed in the lab has provided crucial insights
0 Comments
Amidst rising tensions between the United States and China, the U.S. government recently issued draft rules aimed at restricting or requiring notification of certain investments in artificial intelligence and other technology sectors in China that could potentially threaten U.S. national security. These rules were proposed in response to an executive order signed by President Joe
0 Comments
Bill Maher’s recent comments on Real Time highlighted a key issue within the Hollywood industry – the U.S. release of the film ‘The Apprentice.’ Despite positive buzz and international distribution deals, the film’s journey to American audiences has hit a roadblock. Maher’s frustration with the delay in releasing the film is a clear sign of
0 Comments
The current tax laws in India regarding cryptocurrencies have been a point of contention for both the government and the crypto community. Since 2022, India has imposed a 30 percent tax on all crypto gains, making it the highest among comparative economies like Ukraine, Canada, and the US. Additionally, the government deducts a one percent
0 Comments
In 2022, an unsettling incident occurred at the San Francisco home of Rep. Nancy Pelosi and her husband, Paul Pelosi. A man named David DePape broke into their home and attacked Paul Pelosi with a hammer. Following the break-in, DePape was found guilty in both state and federal cases for this violent act. The attack
0 Comments
As Inside Out 2 continues to dominate the box office, the Disney/Pixar sequel has now surpassed $481.4M worldwide. With an impressive $23.4M added in 43 international box office markets, the film’s offshore total has reached $226.7M. Noteworthy launches in markets like Brazil have contributed to its success, with the movie earning the title of the
0 Comments
The presentation by Roy Herbst, MD, PhD, from Yale Cancer Center highlighted the significant advancements in the treatment of EGFR-mutated non-small cell lung cancer (NSCLC) with osimertinib. The discussion focused on the outcomes from the LAURA and ADAURA trials, particularly the improvements in progression-free survival (PFS) in patients with stage III disease. This is a
0 Comments